Cargando…
A test of miR-128-3p and miR-33a-5p in serum exosome as biomarkers for auxiliary diagnosis of non-small cell lung cancer
BACKGROUND: Lung cancer is the malignant tumor with the highest incidence and mortality rate in the world today, and non-small cell lung cancer (NSCLC) is its most common type. However, there is still a paucity of specific tumor markers for lung cancer screening. Herein, we detected and compared the...
Autores principales: | Li, Mengxing, Liu, Tao, Cheng, Wen, Jin, Hai, Wang, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267929/ https://www.ncbi.nlm.nih.gov/pubmed/37324093 http://dx.doi.org/10.21037/jtd-23-398 |
Ejemplares similares
-
A two-miRNA signature (miR-33a-5p and miR-128-3p) in whole blood as potential biomarker for early diagnosis of lung cancer
por: Pan, Jinchang, et al.
Publicado: (2018) -
Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer
por: Block, Ines, et al.
Publicado: (2018) -
Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease
por: Citterio, Lorenzo Agostino, et al.
Publicado: (2023) -
miR-23a binds to p53 and enhances its association with miR-128 promoter
por: Li, Jincheng, et al.
Publicado: (2015) -
Diagnostic and prognostic value of serum miR-9-5p and miR-128-3p levels in early-stage acute ischemic stroke
por: Wang, Qi, et al.
Publicado: (2021)